We are live on ! Find out more
IART icon

Integra LifeSciences
IART

280 hedge funds and large institutions have $4.16B invested in Integra LifeSciences in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 100 increasing their positions, 88 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 23

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more call options, than puts

Call options by funds: $5.85M | Put options by funds: $4.52M

14% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 88

7% more funds holding

Funds holding: 262 → 280 (+18)

5% more capital invested

Capital invested by funds: $3.95B → $4.16B (+$210M)

1.8% less ownership

Funds ownership: 82.73% → 80.93% (-1.8%)

Holders
280
Holders Change
+18
Holders Change %
+6.87%
% of All Funds
6.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
42
Increased
100
Reduced
88
Closed
23
Calls
$5.85M
Puts
$4.52M
Net Calls
+$1.33M
Net Calls Change
+$1.21M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$23.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$22.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
4
Brown Advisory
Brown Advisory
Maryland
+$13.9M
5
Millennium Management
Millennium Management
New York
+$12.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.7M
2
Capital World Investors
Capital World Investors
California
-$63.5M
3
Capital International Investors
Capital International Investors
California
-$27.3M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$16.4M
5
State Street
State Street
Massachusetts
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$544M +$22.9K +385 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$408M +$21.1M +354,746 +6%
BlackRock
3
BlackRock
New York
$394M -$5.21M -87,479 -1%
CIP
4
Champlain Investment Partners
Vermont
$341M -$4.85M -81,470 -1%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$303M +$22.1M +370,471 +8%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$194M -$1.34M -22,408 -0.7%
ClearBridge Investments
7
ClearBridge Investments
New York
$157M +$5.99M +100,474 +4%
State Street
8
State Street
Massachusetts
$110M -$14.5M -242,914 -12%
Brown Advisory
9
Brown Advisory
Maryland
$101M +$13.9M +232,543 +16%
Capital International Investors
10
Capital International Investors
California
$77.1M -$27.3M -458,245 -26%
Invesco
11
Invesco
Georgia
$71.2M -$2.37M -39,741 -3%
ACH
12
ArrowMark Colorado Holdings
Colorado
$59.6M -$7.7M -129,264 -12%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$51.9M -$98.7M -1,656,168 -66%
VNIM
14
Vaughan Nelson Investment Management
Texas
$51.8M +$758K +12,728 +1%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$51.7M -$622K -10,437 -1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$50M +$240K +4,033 +0.5%
HRCM
17
Hood River Capital Management
Florida
$48.3M +$12M +202,008 +34%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$47.7M +$23.5M +394,834 +99%
Jennison Associates
19
Jennison Associates
New York
$44M -$5.39M -90,502 -11%
Fisher Asset Management
20
Fisher Asset Management
Washington
$43.7M -$3.16M -53,108 -7%
Norges Bank
21
Norges Bank
Norway
$43.5M +$482K +8,089 +1%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$43.2M -$784K -13,165 -2%
ACM
23
Atlanta Capital Management
Georgia
$40.9M -$273K -4,583 -0.7%
Northern Trust
24
Northern Trust
Illinois
$39.8M -$1.3M -21,754 -3%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$34.6M +$5.04M +84,549 +17%
1
2 3 4 5

IART Hedge Fund Activity: Q3 2019 in Review

280 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2019, worth a combined $4.16B — up 5.3% from $3.95B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new IART positions and 23 closed out — a net gain of 19 holders — while 100 added to existing stakes and 88 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $23.5M. The largest seller was Fidelity Investments, cutting an estimated $98.7M.

  • 280 institutional investors held Integra LifeSciences (IART) as of Q3 2019, up from 262 in Q2 2019.
  • Funds reported $4.16B of Integra LifeSciences stock for Q3 2019, up 5.3% quarter-over-quarter.
  • 42 funds opened new Integra LifeSciences positions in Q3 2019 and 23 closed out, a net change of +19 holders.
  • The largest Integra LifeSciences buyer in Q3 2019 was Point72 Asset Management, an estimated $23.5M added.
  • The largest Integra LifeSciences seller in Q3 2019 was Fidelity Investments, an estimated $98.7M sold.

Based on aggregated 13F filings for Q3 2019.